Literature DB >> 1525672

Ethanol-induced locomotor activity: involvement of central nicotinic acetylcholine receptors?

O Blomqvist1, B Söderpalm, J A Engel.   

Abstract

Ethanol and nicotine have many psychopharmacological effects in common, which could explain why coadministration of these compounds often is observed in individuals. In the present study in mice, low doses of nicotine in a complex manner altered the locomotor activity (LMA) stimulatory effect of different doses of ethanol, whereas the quaternary nicotine analog tetramethylammonium did not. The blood-brain-barrier-penetrating nicotine antagonist mecamylamine (2.0 and 4.0 mg/kg), but not the quaternary nicotine antagonist hexamethonium (4.0 and 8.0 mg/kg), partly counteracted the LMA stimulatory effect of ethanol (3.0 g/kg) in doses having no LMA reducing effects per se. Furthermore, the dihydroxyphenylacetic acid (DOPAC)/dopamine (DA) quotient increase in mouse brain after ethanol 3.0 g/kg was partly antagonized by mecamylamine 2.0 and 4.0 mg/kg. These results suggest that part of the LMA and DA turnover-increasing effect of ethanol is mediated via activation of central nicotinic acetylcholine receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525672     DOI: 10.1016/0361-9230(92)90023-q

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  27 in total

1.  Neurotoxicity and substance abuse: further fuel for regulatory dilemma.

Authors:  T Archer; T Palomo; R M Kostrzewa
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

Review 2.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

3.  The α6 nicotinic acetylcholine receptor subunit influences ethanol-induced sedation.

Authors:  Helen M Kamens; Nicole R Hoft; Ryan J Cox; Jill H Miyamoto; Marissa A Ehringer
Journal:  Alcohol       Date:  2012-05-07       Impact factor: 2.405

4.  Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats.

Authors:  Susmita Chatterjee; Pia Steensland; Jeffrey A Simms; Joan Holgate; Jotham W Coe; Raymond S Hurst; Christopher L Shaffer; John Lowe; Hans Rollema; Selena E Bartlett
Journal:  Neuropsychopharmacology       Date:  2010-11-03       Impact factor: 7.853

Review 5.  Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.

Authors:  S Chatterjee; S E Bartlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

6.  Decreased Beta(2)*-nicotinic acetylcholine receptor availability after chronic ethanol exposure in nonhuman primates.

Authors:  Kelly P Cosgrove; Tracy Kloczynski; Frederic Bois; Brian Pittman; Gilles Tamagnan; John P Seibyl; John H Krystal; Julie K Staley
Journal:  Synapse       Date:  2010-09       Impact factor: 2.562

7.  Nicotine infusion in the wake-promoting basal forebrain enhances alcohol-induced activation of nucleus accumbens.

Authors:  Rishi Sharma; Samuel Dumontier; David DeRoode; Pradeep Sahota; Mahesh M Thakkar
Journal:  Alcohol Clin Exp Res       Date:  2014-10-21       Impact factor: 3.455

8.  The Nicotinic α6-Subunit Selective Antagonist bPiDI Reduces Alcohol Self-Administration in Alcohol-Preferring Rats.

Authors:  Jirawoot Srisontiyakul; Hanna E Kastman; Elena V Krstew; Piyarat Govitrapong; Andrew J Lawrence
Journal:  Neurochem Res       Date:  2016-08-29       Impact factor: 3.996

9.  The alpha 3 subunit gene of the nicotinic acetylcholine receptor is a candidate gene for ethanol stimulation.

Authors:  H M Kamens; C S McKinnon; N Li; M L Helms; J K Belknap; T J Phillips
Journal:  Genes Brain Behav       Date:  2008-09-30       Impact factor: 3.449

Review 10.  How can we use our knowledge of alcohol-tobacco interactions to reduce alcohol use?

Authors:  Sherry A McKee; Andrea H Weinberger
Journal:  Annu Rev Clin Psychol       Date:  2012-11-13       Impact factor: 18.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.